Open access
Sep 2026
Immune-related hallmark pathway heterogeneity identifies a prognostic risk signature with independent external validation in glioblastoma
It is demonstrated that immune-related hallmark pathway activity contributes substantially to glioblastoma biological heterogeneity and patient prognosis, and the proposed pathway-based prognostic framework provides a biologically interpretable approach for survival stratification.
Ahmed M. Abdelmaguid, Rasha M. A. Eltanany, Manal F. El-khadragy et al.
· Discover Oncology · 0 citations